CELL THERAPY: Development of new therapies for brain tumours using encapsulated cell technology

• Unité de recherche: PCRD EU
• Numéro de projet: 02.0444
• Titre du projet anglais: CELL THERAPY: Development of new therapies for brain tumours using encapsulated cell technology

Mots-clé (Anglais)

Life Sciences; Medicine; Health; Scientific Research

Autre Numéro de projet (Anglais)

EU project number: QLG1-2000-00815

Programme de recherche (Anglais)

EU-programme: 5. Frame Research Programme - 1.1.3 The 'cell factory'

Description succincte (Anglais)

See abstract

Résumé des résultats (Abstract) (Anglais)

The main goal of this proposal is to develop, produce and validate a cell-based targeted therapeutic delivery system comprising cells encapsulated in an ultrapure alginate gel. Cell lines will be developed which produce tumour growth inhibitory substances such as antiangiogenic proteins (endostatin, angiostatin) as well as antibodies to cancer cell growth receptors. The encapsulated cell prototype will be evaluated for efficacy against brain tumours, for which there is no adequate treatment today. An ultrapure alginate will be developed and characterised which will meet regulatory standards for implantation into the brain. The final step in the proposal is to document the preclinical efficacy of this alginate encapsulated cell therapy towards brain tumours in small animal models such as rats and in spontaneously occurring brain tumours in dogs.

Références bases de données (Anglais)

Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. [phone]
Swiss Project-Number: 02.0444